ARKG: Cathie Wood's Biotech Product Is In Rally Mode
Source: SeekingAlpha
2026-01-28 17:50:15 ET
Healthcare stocks have come on strong since last August. What's more, low-quality, high-risk biotech names have helped support the global equity rally ever since the low last April. Cathie Wood’s ARK Genomic Revolution ETF ( ARKG ) has, not surprisingly, outperformed both the large-cap-dominated Health Care Select Sector ETF ( XLV ) and the S&P 500 ETF ( SPY ) in the last year. ...
Read the full article on Seeking Alpha
For further details see:
ARKG: Cathie Wood's Biotech Product Is In Rally Mode
ARK Genomic Revolution ETF
NASDAQ: ARKG
ARKG Trading
1.20% G/L:
$ Last:
223,320 Volume:
$36.28 Open:
